Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Active
Last updated: January 7, 2026
Nestorone + Estradiol Vaginal Ring

Segesterone Acetate + Estradiol Vaginal Ring

Active
Last updated: January 7, 2026
Na,K-ATPase α4 Inhibitors

Ouabain Derivatives

Inactive
Last updated: January 7, 2026
MENTR Implant

MENT Acetate Implant, 7alpha-Methyl-19-Nortestosterone, MENTR

Active
Last updated: January 7, 2026
Twirla® Contraceptive Patch

Levonorgestrel + Ethinyl Estradiol Patch, AG200-15

Inactive
Last updated: January 7, 2026
Meloxicam Vaginal Ring
Inactive
Last updated: January 7, 2026
Lupeol

Lup-20(29)-en-3-ol, (3beta)-, Fagarasterol, Clerodol, Monogynol B

Active
Last updated: January 7, 2026
Low-Profile Copper IUD MPT
Active
Last updated: January 7, 2026
Long-Acting Etonogestrel Microsphere Injectable

DARE-204, DARE-214

Active
Last updated: January 7, 2026
Levonorgestrel Patch

AG890

Active
Last updated: January 7, 2026
Levonorgestrel Butanoate Injectable